BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10353583)

  • 1. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness.
    Nathan RA; Minkwitz MC; Bonuccelli CM
    Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
    Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
    Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.
    Pearlman DS; Lampl KL; Dowling PJ; Miller CJ; Bonuccelli CM
    Clin Ther; 2000 Jun; 22(6):732-47. PubMed ID: 10929920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.
    Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
    Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
    Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.
    Nathan RA; Bernstein JA; Bielory L; Bonuccelli CM; Calhoun WJ; Galant SP; Hanby LA; Kemp JP; Kylstra JW; Nayak AS; O'Connor JP; Schwartz HJ; Southern DL; Spector SL; Williams PV
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):935-42. PubMed ID: 9847434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma.
    Ramsdell JW; Fish L; Graft D; Higgins N; Kavuru M; Pleskow W; Banerji D
    Ann Allergy Asthma Immunol; 1998 May; 80(5):385-90. PubMed ID: 9609607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease.
    Lal S; Dorow PD; Venho KK; Chatterjee SS
    Chest; 1993 Aug; 104(2):438-47. PubMed ID: 8393398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.
    Centanni S; Santus P; Casanova F; Di Marco F; Brazzola G; Canonica GW
    Drugs Exp Clin Res; 2000; 26(4):133-8. PubMed ID: 11109513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
    Spector SL; Smith LJ; Glass M
    Am J Respir Crit Care Med; 1994 Sep; 150(3):618-23. PubMed ID: 8087328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma.
    Bousquet J; Aubert B; Bons J
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):189-94. PubMed ID: 8595540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?
    Schwartz HJ; Blumenthal M; Brady R; Braun S; Lockey R; Myers D; Mansfield L; Mullarkey M; Owens G; Ratner P; Repsher L; van As A
    Chest; 1996 Apr; 109(4):945-52. PubMed ID: 8635375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily versus as-needed corticosteroids for mild persistent asthma.
    Boushey HA; Sorkness CA; King TS; Sullivan SD; Fahy JV; Lazarus SC; Chinchilli VM; Craig TJ; Dimango EA; Deykin A; Fagan JK; Fish JE; Ford JG; Kraft M; Lemanske RF; Leone FT; Martin RJ; Mauger EA; Pesola GR; Peters SP; Rollings NJ; Szefler SJ; Wechsler ME; Israel E;
    N Engl J Med; 2005 Apr; 352(15):1519-28. PubMed ID: 15829533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
    Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
    J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
    Zhang J; Yu C; Noonan G; Reiss TF
    Clin Ther; 2002 Apr; 24(4):574-82. PubMed ID: 12017402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.